To evaluate whether lncRNA TUG1 influenced the resistance of oxaliplatin in CRC, the lncRNA TUG1 was silenced in CD133+/CD44+ cells isolated from HCT-116 and SW480 cells, and then, the cells were treated with different concentrations of oxaliplatin. The gene discussed is PROM1; the disease is colorectal carcinoma.